Skip to main content
Harbin Pharmaceutical Group Co.,Ltd. logo

Harbin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600664 ISIN · CNE0000009T3 LEI · 300300G0L086UJ23MI26 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,824 across all filing types
Latest filing 2023-06-15 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600664

About Harbin Pharmaceutical Group Co.,Ltd.

https://www.hayao.com/

Harbin Pharmaceutical Group Co., Ltd. specializes in the research, development, manufacture, and distribution of a diverse range of pharmaceutical and healthcare products. The company's portfolio includes antibiotics, over-the-counter (OTC) medicines, health supplements, traditional Chinese medicines, and animal health products. It operates through several specialized subsidiaries and maintains a significant presence in the production of penicillins and cephalosporins. A key strategic focus involves the health and nutrition sector, bolstered by the acquisition of global nutrition brand GNC. The company leverages large-scale manufacturing capabilities and an extensive distribution network to serve both domestic and international markets. Its operations emphasize technological innovation and quality control across its integrated supply chain, from raw material production to finished dosage forms.

Recent filings

Filing Released Lang Actions
哈药集团股份有限公司2022年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2022 Annual General Meeting Resolution Announcement" and details the resolutions passed at the 2022 annual shareholders meeting held on June 15, 2023. It includes voting results on various proposals such as the 2022 annual report, financial budget, profit distribution, appointment of auditors, and amendments to the company bylaws. The document is a formal announcement of the voting results from the AGM, not the full annual report or financial statements themselves. The length is about 4403 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-06-15 Chinese
哈药集团股份有限公司2022年年度股东大会会议材料
AGM Information Classification · 100% confidence The document is titled as "2022 年年度股东大会会议材料" which translates to "2022 Annual General Meeting (AGM) Meeting Materials". It contains detailed agenda items for the AGM, including the full annual report, financial budget, profit distribution plan, auditor reappointment, credit application, board and supervisory reports, independent director reports, and amendments to company articles. The document is comprehensive and clearly intended as the materials presented and discussed at the AGM. It is not just an announcement or a brief summary but the actual meeting materials. Therefore, the document fits the category of AGM Information (AGM-R).
2023-05-30 Chinese
哈药集团股份有限公司九届三十七次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board resolution announcement from Harbin Pharmaceutical Group Co., Ltd. It details the decisions made at the 37th meeting of the 9th Board of Directors, including the scheduling of the 2022 Annual General Meeting and internal management adjustments. The document is an official announcement of board decisions and changes in internal management structure, not a full annual report or financial statement. It fits the category of Board/Management Information (MANG). The document length is short and contains no financial data or detailed report content, confirming it is a management announcement.
2023-05-25 Chinese
哈药集团股份有限公司关于召开2022年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about the convening of the 2022 Annual General Meeting (AGM) of 哈药集团股份有限公司, including details such as the date, voting methods, agenda items, and proxy forms. It does not contain the actual annual report or financial statements but rather informs shareholders about the meeting and the matters to be discussed and voted on. The document length is 3493 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM.
2023-05-25 Chinese
哈药集团股份有限公司关于参加黑龙江辖区上市公司2023年投资者网上集体接待日活动暨2022年度业绩说明会的公告
Investor Presentation Classification · 90% confidence The document is an announcement about the company's participation in an online investor collective reception day and 2022 annual performance explanation meeting. It provides details about the meeting time, location, participants, and how investors can interact. It does not contain actual financial statements or detailed financial analysis but rather informs about an upcoming event where such information may be discussed. The document length is short (1329 characters) and serves as a notice for an investor presentation event rather than the presentation or report itself. Therefore, it fits best under the category of Investor Presentation (IP) as it is a detailed presentation for investors focusing on financials, strategy, and market position, or more precisely, an announcement of such a presentation. However, since it is an announcement of the event rather than the presentation materials themselves, it aligns more closely with Investor Presentation (IP) category as per definitions, which includes detailed presentations for investors. The document is not a report publication announcement (RPA) because it does not mention a report being attached or published, but an event to discuss the report. Hence, the classification is Investor Presentation (IP).
2023-05-09 Chinese
哈药集团股份有限公司关于公司高级管理人员辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a senior management member (the company's vice president). It is a formal notice from the board about a change in senior management personnel. There is no financial data, report, or presentation included. This fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming the classification.
2023-05-08 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.